Curie.Bio
Jing (Jenny) Shan is a seasoned professional in the biopharmaceutical industry with extensive experience in biologics research and development. Currently serving as Vice President of External R&D Biologics at Curie.Bio, Jing (Jenny) Shan has previously held senior leadership roles in translational research, biologics discovery, and external biologics at Apogee Therapeutics, EQRx, and The Janssen Pharmaceutical Companies of Johnson & Johnson. Additionally, Jing (Jenny) Shan has a background as a Principal Scientist in the New Venture Lab at Moderna, showcasing a strong commitment to advancing biologics innovation.
This person is not in any teams
Curie.Bio
2 followers
Curie.Bio is a founder-focused seed-stage venture firm combined with an industry-grade therapeutics accelerator focused on one thing: helping entrepreneurial founders launch viable therapeutics companies. Curie.Bio does this by giving founders access to a team of the world’s best drug hunters and drug makers, seed capital, and best-of-breed services - everything a founder needs to get from concept to a compelling quality dataset that enables an awesome Series A financing. In a nutshell, we want founders in control of their own company and focused on their area of expertise and creativity, while we help make the rest happen smoothly.